CompuMed to acquire Northeast Imaging
CompuMed of Manhattan Beach, CA, announced this month its intention to acquire the assets of Northeast Imaging Center of East Orange, NJ. The deal will increase CompuMed's revenues by about 50% and will give the firm access to a medical imaging operation
CompuMed of Manhattan Beach, CA, announced this month its intention to acquire the assets of Northeast Imaging Center of East Orange, NJ. The deal will increase CompuMed's revenues by about 50% and will give the firm access to a medical imaging operation in which it could potentially use its products. Northeast Imaging's medical imaging center supplies outpatient care and brings in annual revenues of approximately $1 million. According to CompuMed executives, there will be no personnel changes, but administrative operations will be centralized.
CompuMed's products and services include the developmental Digital OsteoView 2000, a bone-density and arthritis testing device, the OsteoGram bone-density testing software, telemedicine services for cardiology, and online computer interpretation of electrocardiograms. Despite the company's R&D activities, it has had difficulty building a solid revenue stream: The company estimates its 1997 sales at $1.75 million.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Study Explores Impact of Insurance on Treatment and Referrals for Patients with Uterine Fibroids
February 19th 2025Women with uterine fibroids and Medicaid coverage are significantly more likely to be treated with uterine artery embolization than those with commercial insurance, according to newly published research.
